Literature DB >> 14590160

Practice effects, test-retest stability, and dual baseline assessments with the California Verbal Learning Test in an HIV sample.

K Duff1, H J Westervelt, R J McCaffrey, R F Haase.   

Abstract

Repeated neuropsychological assessments have been recently employed to investigate the natural course and effects of interventions in individuals with human immunodeficiency virus (HIV) infection. Important considerations when interpreting serial assessments are the roles of practice effects and test-retest reliability on follow-up performance. Although several statistical and methodological controls have been proposed for minimizing practice effects, they have not been empirically tested in HIV samples. Three groups (HIV+/symptomatic, HIV+/asymptomatic, HIV- "at risk" controls) were administered the California Verbal Learning Test (CVLT) twice with a brief test-retest interval. Significant practice effects were observed on six of the CVLT measures. Test-retest stability coefficients were reported. A third and fourth administration of the CVLT was conducted to observe the impact of the dual baseline assessment approach on test performance. Trend analyses indicated that the dual baseline approach is a viable method for minimizing practice effects. The dual baseline approach also lead to improvement in a number of the stability coefficients. Limitations and future directions are discussed.

Entities:  

Year:  2001        PMID: 14590160

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  20 in total

1.  Psychometric and measurement properties of concussion assessment tools in youth sports.

Authors:  Tamara C Valovich McLeod; William B Barr; Michael McCrea; Kevin M Guskiewicz
Journal:  J Athl Train       Date:  2006 Oct-Dec       Impact factor: 2.860

2.  Validity, reliability and sensitivity of the NORLA-6: Naming and oral reading for language in aphasia 6-point scale.

Authors:  Laura L Pitts; Rosalind Hurwitz; Jaime B Lee; Julia Carpenter; Leora R Cherney
Journal:  Int J Speech Lang Pathol       Date:  2017-02-08       Impact factor: 2.484

3.  Practice effects in the prediction of long-term cognitive outcome in three patient samples: a novel prognostic index.

Authors:  Kevin Duff; Leigh J Beglinger; Susan K Schultz; David J Moser; Robert J McCaffrey; Richard F Haase; Holly J K Westervelt; Douglas R Langbehn; Jane S Paulsen
Journal:  Arch Clin Neuropsychol       Date:  2006-12-04       Impact factor: 2.813

4.  Practice effects associated with repeated assessment of a clinical test of reaction time.

Authors:  Gianluca Del Rossi; Alfonso Malaguti; Samanta Del Rossi
Journal:  J Athl Train       Date:  2014-03-27       Impact factor: 2.860

5.  Age-related differences and reliability on computerized and paper-and-pencil neurocognitive assessment batteries.

Authors:  Johna K Register-Mihalik; Daniel L Kontos; Kevin M Guskiewicz; Jason P Mihalik; Robert Conder; Edgar W Shields
Journal:  J Athl Train       Date:  2012 May-Jun       Impact factor: 2.860

Review 6.  Neuropsychological sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a critical review.

Authors:  Steven Paul Woods; Julie A Fields; Alexander I Tröster
Journal:  Neuropsychol Rev       Date:  2002-06       Impact factor: 7.444

Review 7.  Developing a Cognition Endpoint for Traumatic Brain Injury Clinical Trials.

Authors:  Noah D Silverberg; Paul K Crane; Kristen Dams-O'Connor; James Holdnack; Brian J Ivins; Rael T Lange; Geoffrey T Manley; Michael McCrea; Grant L Iverson
Journal:  J Neurotrauma       Date:  2016-06-27       Impact factor: 5.269

8.  The Indiana faces in places test: preliminary findings on a new visuospatial memory test in patients with mild cognitive impairment.

Authors:  Leigh J Beglinger; Kevin Duff; David J Moser; Stephen A Cross; David A Kareken
Journal:  Arch Clin Neuropsychol       Date:  2009-08-13       Impact factor: 2.813

9.  Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection.

Authors:  Meredith E Childers; Steven Paul Woods; Scott Letendre; J Allen McCutchan; Debralee Rosario; Igor Grant; Monica Rivera Mindt; Ronald J Ellis
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

10.  Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial.

Authors:  Erin L Abner; Brandon C Dennis; Melissa J Mathews; Marta S Mendiondo; Allison Caban-Holt; Richard J Kryscio; Frederick A Schmitt; John J Crowley
Journal:  Trials       Date:  2012-11-20       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.